v3.26.3
Revenue - Additional Information (Details) - USD ($)
1 Months Ended
Feb. 29, 2024
Sep. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Revenue Recognition            
Current deferred revenue   $ 102,201,000 $ 140,053,000      
Noncurrent deferred revenue   330,011,000 358,943,000      
Billed contracts receivable   33,100,000 95,600,000      
Unbilled contracts receivable   16,100,000 10,800,000      
Allowance for credit losses   0   $ 0    
Amount of transaction price not yet satisfied   500,000,000        
Deferred revenue   432,212,000 498,996,000 $ 501,356,000   $ 1,121,886,000
Claim related to performance obligation         $ 23,000,000.0  
Other current liabilities   123,652,000 137,778,000      
Other non-current liabilities   151,391,000 $ 239,068,000      
Australia Revenue Agency Member            
Revenue Recognition            
Deferred revenue refund   92,500,000        
Noncurrent deferred revenue   69,800,000        
Australian APA            
Revenue Recognition            
Advanced payment paid   31,000,000        
Current deferred revenue   64,100,000        
Gavi Settlement Agreement            
Revenue Recognition            
Litigation settlement, expense $ 80,000,000          
Settlement Agreement            
Revenue Recognition            
Litigation settlement, expense 400,000,000          
Grants receivable 225,000,000 225,000,000.0        
Litigation settlement, amount awarded to other party 75,000,000          
Other current liabilities   80,000,000.0        
Other non-current liabilities   $ 130,000,000.0        
Gavi Advance Purchase Agreement- COVAX Facility            
Revenue Recognition            
Collaborative agreement, upfront payment amount $ 700,000,000